COVID-19 and Cancer

Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study

(2021) Akshay Sharma et al.   Lancet Haematology

Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score

(2021) Gino M Dettorre et al.   Journal for ImmunoTherapy of Cancer

Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study

(2021) David J. Pinato et al.   EUROPEAN JOURNAL OF CANCER

Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19

(2021) Michael A. Thompson et al.   JAMA Oncology

Tocilizumab not associated with increased infection risk after CAR T - Implications for COVID-19?

(2020) Matthew J Frigault et al.   BLOOD

COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study

(2020) Lennard Y W Lee et al.   LANCET

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

(2020) Nicole M Kuderer et al.   LANCET

Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study

(2020) Kunyu Yang et al.   LANCET ONCOLOGY

Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study

(2020) Sofia Ramiro et al.   ANNALS OF THE RHEUMATIC DISEASES

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

(2020) Marina Chiara Garassino et al.   LANCET ONCOLOGY

Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study

(2020) Donna R Rivera et al.   Cancer Discovery

Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients.

(2020) David J Pinato et al.   Cancer Discovery

Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe

(2020) David J. Pinato et al.   Cancers

LBA75 Defining COVID-19 outcomes in thoracic cancer patients: TERAVOLT (Thoracic cancERs international coVid 19 cOLlaboraTion)

(2020) J. Baena Espinar et al.   ANNALS OF ONCOLOGY

1670O Prospective data of first 1,797 hospitalised patients with cancer and COVID-19 derived from the COVID-19 Clinical Information Network and international Severe Acute Respiratory and emerging Infections Consortium, WHO Coronavirus Clinical Characterisation Consortium

(2020) C. Palmieri et al.   ANNALS OF ONCOLOGY

COVID-19 and Cancer: Current Challenges and Perspectives

(2020) Ziad Bakouny et al.   CANCER CELL

The HOLA COVID-19 Study: An International Effort to Determine How COVID-19 Has Impacted Oncology Practices in Latin America

(2020) Carolina Bernabe-Ramirez et al.   CANCER CELL

Randomized Controlled Trials vs Real-World Data in the COVID-19 Era: A False Narrative

(2020) Gary H Lyman et al.   CANCER INVESTIGATION

Dutch Oncology COVID-19 Consortium (DOCC): outcome of COVID-19 in patients with cancer in a nationwide cohort study

(2020) K. de Joode et al.   EUROPEAN JOURNAL OF CANCER

Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19

(2020) Pierre-François Dequin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19

(2020) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Chemotherapy and COVID-19 Outcomes in Patients With Cancer

(2020) Justin Jee et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer and COVID-19 – Authors' reply

(2020) Nicole M Kuderer et al.   LANCET

Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set

(2020) Ajai Chari et al.   BLOOD

Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection

(2020) QuanQiu Wang et al.   JAMA Oncology

Use of Real-World Electronic Health Records to Estimate Risk, Risk Factors, and Disparities for COVID-19 in Patients With Cancer

(2020) Aakash Desai et al.   JAMA Oncology

Scientific Rigor in the Age of COVID-19

(2020) Yu Shyr et al.   JAMA Oncology

Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub

(2020) William A. Wood et al.   Blood Advances

The Evolving Use of Electronic Health Records (EHR) for Research

(2019) Ellen Kim et al.   SEMINARS IN RADIATION ONCOLOGY